AJP - Heart Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 290: H1469-H1473, 2006. First published November 18, 2005; doi:10.1152/ajpheart.00181.2005
0363-6135/06 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/4/H1469    most recent
00181.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (18)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lankford, A. R.
Right arrow Articles by Yang, Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lankford, A. R.
Right arrow Articles by Yang, Z.

Effect of modulating cardiac A1 adenosine receptor expression on protection with ischemic preconditioning

Amy R. Lankford,1,2 Jiang-Ning Yang,4 Roselyn Rose'Meyer,5 Brent A. French,2,3 G. Paul Matherne,1,2 Bertil B. Fredholm,4 and Zequan Yang2,3

1Department of Pediatrics, 2Cardiovascular Research Center, and 3Department of Biomedical Engineering, University of Virginia Health System, Charlottesville, Virginia; 4Department of Physiology and Pharmacology, Karolinska Institute, Stockholm, Sweden; and 5Griffith University, Gold Coast, Queensland, Australia

Submitted 22 February 2005 ; accepted in final form 10 November 2005

Activation of A1 adenosine receptors (A1ARs) may be a crucial step in protection against myocardial ischemia-reperfusion (I/R) injury; however, the use of pharmacological A1AR antagonists to inhibit myocardial protection has yielded inconclusive results. In the current study, we have used mice with genetically modified A1AR expression to define the role of A1AR in intrinsic protection and ischemic preconditioning (IPC) against I/R injury. Normal wild-type (WT) mice, knockout mice with deleted (A1KO–/–) or single-copy (A1KO+/–) A1AR, and transgenic mice (A1TG) with increased cardiac A1AR expression underwent 45 min of left anterior descending coronary artery occlusion, followed by 60 min of reperfusion. Subsets of each group were preconditioned with short durations of ischemia (3 cycles of 5 min of occlusion and 5 min of reperfusion) before index ischemia. Infarct size (IF) in WT, A1KO+/–, and A1KO–/– mice was (in % of risk region) 58 ± 3, 60 ± 4, and 61 ± 2, respectively, and was less in A1TG mice (39 ± 4, P < 0.05). A strong correlation was observed between A1AR expression level and response to IPC. IF was significantly reduced by IPC in WT mice (35 ± 3, P < 0.05 vs. WT), A1KO+/– + IPC (48 ± 4, P < 0.05 vs. A1KO+/–), and A1TG + IPC mice (24 ± 2, P < 0.05 vs. A1TG). However, IPC did not decrease IF in A1KO–/– + IPC mice (63 ± 2). In addition, A1KO–/– hearts subjected to global I/R injury demonstrated diminished recovery of developed pressure and diastolic function compared with WT controls. These findings demonstrate that A1ARs are critical for protection from myocardial I/R injury and that cardioprotection with IPC is relative to the level of A1AR gene expression.

myocardial ischemia-reperfusion injury; functional genomics; genetically altered mice



Address for reprint requests and other correspondence: A. R. Lankford, Dept. of Pediatrics, Univ. of Virginia Health System Box 800386, MR4 Bldg., Charlottesville, VA 22908 (e-mail: arl2b{at}virginia.edu)




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. T. Fassett, X. Xu, X. Hu, G. Zhu, J. French, Y. Chen, and R. J. Bache
Adenosine regulation of microtubule dynamics in cardiac hypertrophy
Am J Physiol Heart Circ Physiol, August 1, 2009; 297(2): H523 - H532.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
C. C. Wendler, M. Busovsky-McNeal, S. Ghatpande, A. Kalinowski, K. S. Russell, and S. A. Rivkees
Embryonic caffeine exposure induces adverse effects in adulthood
FASEB J, April 1, 2009; 23(4): 1272 - 1278.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. H. Rork, K. L. Wallace, D. P. Kennedy, M. A. Marshall, A. R. Lankford, and J. Linden
Adenosine A2A receptor activation reduces infarct size in the isolated, perfused mouse heart by inhibiting resident cardiac mast cell degranulation
Am J Physiol Heart Circ Physiol, November 1, 2008; 295(5): H1825 - H1833.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. C. Morote-Garcia, P. Rosenberger, J. Kuhlicke, and H. K. Eltzschig
HIF-1-dependent repression of adenosine kinase attenuates hypoxia-induced vascular leak
Blood, June 15, 2008; 111(12): 5571 - 5580.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Eckle, M. Faigle, A. Grenz, S. Laucher, L. F. Thompson, and H. K. Eltzschig
A2B adenosine receptor dampens hypoxia-induced vascular leak
Blood, February 15, 2008; 111(4): 2024 - 2035.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. H.-C. Lin, N. Lou, N. Kang, T. Takano, F. Hu, X. Han, Q. Xu, D. Lovatt, A. Torres, K. Willecke, et al.
A Central Role of Connexin 43 in Hypoxic Preconditioning
J. Neurosci., January 16, 2008; 28(3): 681 - 695.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. Eckle, T. Krahn, A. Grenz, D. Kohler, M. Mittelbronn, C. Ledent, M. A. Jacobson, H. Osswald, L. F. Thompson, K. Unertl, et al.
Cardioprotection by Ecto-5'-Nucleotidase (CD73) and A2B Adenosine Receptors
Circulation, March 27, 2007; 115(12): 1581 - 1590.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J. D. Joo, M. Kim, V. D. D'Agati, and H. T. Lee
Ischemic Preconditioning Provides Both Acute and Delayed Protection against Renal Ischemia and Reperfusion Injury in Mice
J. Am. Soc. Nephrol., November 1, 2006; 17(11): 3115 - 3123.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Eckle, A. Grenz, D. Kohler, A. Redel, M. Falk, B. Rolauffs, H. Osswald, F. Kehl, and H. K. Eltzschig
Systematic evaluation of a novel model for cardiac ischemic preconditioning in mice
Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2533 - H2540.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. R. Morrison, B. Teng, P. J. Oldenburg, L. C. Katwa, J. B. Schnermann, and S. J. Mustafa
Effects of targeted deletion of A1 adenosine receptors on postischemic cardiac function and expression of adenosine receptor subtypes
Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1875 - H1882.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.